The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007
Authors:
- Gul Ruhsar YilmazGYGul Ruhsar Yilmaz
- Turan BuzganTBTuran Buzgan
- Hasan IrmakHIHasan Irmak
- Ahmet SafranASAhmet Safran
- Ramazan UzunRURamazan Uzun
- Mustafa Aydin CevikMCMustafa Aydin Cevik
- Mehmet Ali TorunogluMTMehmet Ali Torunoglu
- 1 May 2009
- journal article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 13 (3) , 380-386
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic feverJournal of Infection, 2007
- Crimean-Congo Hemorrhagic Fever Virus: Genetic Analysis and Tick Survey in TurkeyJournal of Clinical Microbiology, 2006
- Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisitedClinical Microbiology and Infection, 2006
- Crimean-Congo hemorrhagic fever in Southeast of IranJournal of Infection, 2006
- Evaluation of Serum Levels of Interleukin (IL)–6, IL‐10, and Tumor Necrosis Factor–α in Patients with Crimean‐Congo Hemorrhagic FeverThe Journal of Infectious Diseases, 2006
- Crimean–Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapyJournal of Infection, 2006
- Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measuresJournal of Medical Microbiology, 2005
- Crimean-Congo Hemorrhagic Fever in TurkeyEmerging Infectious Diseases, 2004
- Crimean-Congo Hemorrhagic Fever in BulgariaEmerging Infectious Diseases, 2004
- Characteristics of Patients with Crimean-Congo Hemorrhagic Fever in a Recent Outbreak in Turkey and Impact of Oral Ribavirin TherapyClinical Infectious Diseases, 2004